NASDAQ NMS - GLOBAL MARKET · EIKN
-0.53% · -$0.0400 · Vol 847.1K
Market closed · last close 4:00 PM ET · price as of 16:01:19 ET
Eikon Therapeutics Inc

Eikon Therapeutics Inc

Biotechnology
$7.50
Card
Relationship Map

Follow $EIKN

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $EIKN by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
EIKN
Eikon Therapeutics Inc
Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EIKN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EIKN catalysts
About Eikon Therapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2026
Employees
384
Country
US

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.48
Day high
$7.74
Day low
$7.19
Previous close
$7.54
52W high
$16.26
-53.87% from high
52W low
$7.19
3% of range
Market cap
$408.4M
EPS
$-10.1008
Beta
1.70
Shares out
54.2M
Volume
847.1K
1.37× rel vol
Avg volume
619.9K
VWAP
$7.48
Price history computed in-house
1W
+2.32%
1M
-30.10%
3M
-29.11%
SMA 50 $9.63 · below
SMA 200 Not reported · Not reported
52W position 3%

EIKN overview

Veridion Score
59
Registered · 2026-10-08
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EIKN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EIKN Form 4 filings
Public disclosures

Congress activity in EIKN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

EIKN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EIKN in this window.
Lobbying spend

EIKN lobbying filings, year to date.

Registered lobbying filings matched to Eikon Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EIKN in this window.
Loading news for EIKN
Analyst ratings
Sovereign unlock shows live analyst consensus for EIKN.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.